Meanwhile, extramedullary involvement is more frequent in pPCL patients, and could be associated with tumor cells having reduced proportions of adhesion molecules (CD56: bone marrow 40.5% and peripheral blood 37.9%), which impair retention of tumor cells within the bone marrow (31). The gene discussed is NCAM1; the disease is neoplasm.